Lawsuit Filed Against Mylan for Raising Prices of Epi Pen

On November 9, 2016, CPM filed an action against Mylan N.V. alleging that it engaged in unfair business practices when it placed massive price increases on its epi pen products.  Epi pens are essential medical devices for those who suffer from allergies.  Plaintiff alleges that the huge price increases on epi pens are unfair and unjustifiable and that they endanger the lives of vulnerable Californians who cannot afford price increases on necessary medical products.  

View Document(s):